Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:e614-e621
Published online before print August 13, 2009, doi: 10.1161/STROKEAHA.108.520858
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/11/e614    most recent
STROKEAHA.108.520858v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sessler, D. I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sessler, D. I.

(Stroke. 2009;40:e614.)
© 2009 American Heart Association, Inc.


Comments, Opinions, and Reviews

Defeating Normal Thermoregulatory Defenses

Induction of Therapeutic Hypothermia

Daniel I. Sessler, MD

From the Department of Outcomes Research, The Cleveland Clinic, Ohio.

Correspondence to Daniel I. Sessler, MD, Professor and Chair, Department of Outcomes Research, The Cleveland Clinic—P77, Cleveland, OH 44195. E-mail DS{at}OR.org

Therapeutic hypothermia may be useful in various circumstances including stroke. However, core body temperature is normally tightly regulated. Even mild hypothermia in conscious subjects thus provokes vigorous thermoregulatory defenses which are potentially harmful in fragile patients. Furthermore, thermoregulatory responses are effective, which reduces the rate at which hypothermia can be induced. Drugs are thus often given to blunt normal thermoregulatory defenses. General anesthetics profoundly impair thermoregulatory control, but prolonged general anesthesia is rarely practical or appropriate. A variety of other drugs have therefore been evaluated. Most opioids only slightly impair thermoregulatory defenses, but meperidine is considerably more effective than equipotent doses of other opioids. The central {alpha}-2 agonists clonidine and dexmedetomidine are also useful. However, the best overall approach to inducing thermal tolerance appears to be a combination of buspirone and meperidine, which reduces the core temperature triggering shivering to about 33.5°C in doses that maintain adequate ventilation.


Key Words: anesthesia • thermal tolerance • temperature • hypothermia • brain protection